MICROLIGHT CORPORATION OF AMERICA

MicroLight Corporation of America is a pioneer in cold laser therapy, established in 1990 and the first company with FDA clearance to market low-level laser therapy (LLLT) for the non-surgical treatment of pain through adjunctive therapy. The company specializes in the patented 830 nanometer (nm) wavelength Gallium-Aluminum-Arsenide (GaAIAs) laser systems, classified by the FDA as a laser device for adjunctive use in pain therapy. Over 30 years of peer-reviewed clinical studies published on PubMed document that the 830nm wavelength is optimal for treating pain, inflammation, and wound healing. MicroLight's Smart Laser systems are designed for clinical and therapeutic applications, including treatment of carpal tunnel syndrome, arthritis, sports injuries, and deep tissue pain. The company also markets laser systems for veterinary medicine. MicroLight manufactures and supplies laser therapy devices, components, accessories, and provides clinical training and educational resources to medical professionals and practitioners worldwide.